QA
FMED icon

Quattro Advisors’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Quattro Advisors’s Portfolio FMED Stock Details FMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2
Closed -$48 – 230
2025
Q4 		$48 Buy
+2
New +$54 ﹤0.01% 535

Other funds holding FMED

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
VT
Vise Technologies New York $8.83B AUM 27.11% 1-Year Est. Return
BW
BXM Wealth Englewood, Colorado $184M AUM 36.28% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $321M AUM 20.69% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $793M AUM 21.06% 1-Year Est. Return

Quattro Advisors's FMED Position: Q1 2026 in Review

Quattro Advisors sold out of Fidelity Disruptive Medicine ETF (FMED) in Q1 2026, closing a stake of 2 shares — an estimated $48 sold.

Quattro Advisors first reported a position in FMED in Q4 2025 and held it in 1 quarter. The position peaked at $48 in Q4 2025. 11 funds tracked by Wall St. Rank hold FMED as of Q1 2026.

  • Quattro Advisors reported no remaining Fidelity Disruptive Medicine ETF position as of Q1 2026 after selling out during the quarter.
  • Quattro Advisors sold 2 Fidelity Disruptive Medicine ETF shares in Q1 2026, an estimated $48.
  • Quattro Advisors first reported a position in Fidelity Disruptive Medicine ETF in Q4 2025 and held it in 1 quarter.
  • Quattro Advisors's Fidelity Disruptive Medicine ETF position peaked at $48 in Q4 2025.
  • 11 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q1 2026.

Based on Quattro Advisors's 13F filing for Q1 2026, filed 15 May 2026.